BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38513509)

  • 1. Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
    Ali E; Latif F; Mashkoor Y; Sheikh A; Iqbal A; Owais R; Ahmed J; Naveed S; Moeed A; Ullah I; Mughal S
    Asian J Psychiatr; 2024 May; 95():104005. PubMed ID: 38513509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR; Guo H; Németh G; Harsányi J; Thase ME
    Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
    Riesenberg R; Yeung PP; Rekeda L; Sachs GS; Kerolous M; Fava M
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37585254
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
    Durgam S; Earley W; Guo H; Li D; Németh G; Laszlovszky I; Fava M; Montgomery SA
    J Clin Psychiatry; 2016 Mar; 77(3):371-8. PubMed ID: 27046309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.
    Demyttenaere K; Detraux J; Racagni G; Vansteelandt K
    CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Fava M; Durgam S; Earley W; Lu K; Hayes R; Laszlovszky I; Németh G
    Int Clin Psychopharmacol; 2018 Nov; 33(6):312-321. PubMed ID: 30045066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive cariprazine as a novel effective strategy for treating major depressive disorder: A systematic review and meta-analysis.
    Xie M; Qiu Y; Wang M; Wei X; Tao Y; Duan A; Shang J; Gao W; Wang Z
    J Psychiatr Res; 2024 Apr; 172():71-80. PubMed ID: 38367320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.
    Lao KS; He Y; Wong IC; Besag FM; Chan EW
    CNS Drugs; 2016 Nov; 30(11):1043-1054. PubMed ID: 27550371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
    Sachs GS; Yeung PP; Rekeda L; Khan A; Adams JL; Fava M
    Am J Psychiatry; 2023 Mar; 180(3):241-251. PubMed ID: 36789515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.
    Kishi T; Sakuma K; Nomura I; Matsuda Y; Mishima K; Iwata N
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):698-709. PubMed ID: 31350882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Cariprazine in Acute Management of Psychiatric Disorders: a Meta-Analysis of Randomized Controlled Trials.
    Cooper H; Mishriky R; Reyad AA
    Psychiatr Danub; 2020; 32(1):36-45. PubMed ID: 32303028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cariprazine for the Treatment of Schizophrenia: A Review of this Dopamine D3-Preferring D3/D2 Receptor Partial Agonist.
    Citrome L
    Clin Schizophr Relat Psychoses; 2016; 10(2):109-19. PubMed ID: 27440212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study.
    Earley WR; Burgess MV; Khan B; Rekeda L; Suppes T; Tohen M; Calabrese JR
    Bipolar Disord; 2020 Jun; 22(4):372-384. PubMed ID: 31628698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
    Earley W; Burgess MV; Rekeda L; Dickinson R; Szatmári B; Németh G; McIntyre RS; Sachs GS; Yatham LN
    Am J Psychiatry; 2019 Jun; 176(6):439-448. PubMed ID: 30845817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications.
    Yatham LN; Vieta E; McIntyre RS; Jain R; Patel M; Earley W
    Prim Care Companion CNS Disord; 2020 Sep; 22(5):. PubMed ID: 32942346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for treatment-resistant depression in adults.
    Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Efficacy of Dopamine Partial Agonists by Doses for Treatment-Resistant Depression: A Systematic Review and Dose-Response Model-Based Network Meta-analysis.
    Terao I; Kodama W
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):413-417. PubMed ID: 38639435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
    Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
    Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder.
    Vieta E; Earley WR; Burgess MV; Durgam S; Chen C; Zhong Y; Barabássy Á; Németh G
    Int Clin Psychopharmacol; 2019 Mar; 34(2):76-83. PubMed ID: 30531358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
    Maneeton N; Maneeton B; Srisurapanont M; Martin SD
    BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.